HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

valylleucine

RN given refers to all L-isomer

Also Known As:

Val-Leu

Networked: 44 relevant articles (2 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - Dipeptides: 945
      - valylleucine: 44

Experts

1.	Taioli, Emanuela: 2 articles (02/2009 - 01/2007)
2.	Li, Qian: 1 article (10/2021)
3.	Meng, Ling: 1 article (10/2021)
4.	Ren, Zheng: 1 article (10/2021)
5.	Shen, Yiwen: 1 article (10/2021)
6.	Cemin, Henrique S: 1 article (05/2019)
7.	DeRouchey, Joel M: 1 article (05/2019)
8.	Dritz, Steve S: 1 article (05/2019)
9.	Goodband, Robert D: 1 article (05/2019)
10.	Tokach, Mike D: 1 article (05/2019)

Related Diseases

1.	Periodontitis 01/01/1990 - "The degradation of N-carbobenzoxy-gly-gly-arginine-AMC, L-arginine-AMC, glyproline-AMC, L-leucine-AMC, N-alpha-benzoyl-L-arginine-AMC, N-[p-toluenesulphonyl]-gly-pro-arginine-AMC, N-tert-butoxycarbonyl-leu-ser-thr-arginine-AMC, N-tert-butoxycarbonyl-ileu-glut-gly-arginine-AMC and N-tert-butoxycarbonyl-val-leu-lysine-AMC was significantly greater by fluid from the periodontitis group. "
2.	Myocardial Infarction 01/01/2004 - "The Val-->Leu replacement accelerates the rate of the proteolytic activation of FXIII and it seems to provide protection against myocardial infarction. "
3.	Neoplasms (Cancer) 10/01/2021 - "In this study, totally 23 acquired drug-resistant gatekeeper mutations harbored on 17 PTKs involved in diverse cancers were curated, from which only five amino acid types, namely Thr, Met, Val, Leu and Ile, were observed at both wild-type and mutant residues of these clinically occurring gatekeeper sites. " 12/01/2016 - "Growth of fetus and cancer cells under hypoxic conditions and impaired mitochondrial energy requirements of tissues including metabolism of essential branched amino acids (e.g., val, leu, isoleu) will be compared for proposing a working model for future systematic research on cancer biology, prevention and therapy. " 01/01/1982 - "Antiserum against the octapeptide Ac-Met-Asp-Lys-Val-Leu-Asn-Arg-Tyr, including the amino-terminal heptapeptide sequence of the simian virus 40 (SV40) large tumor (T) and small T antigens, cross-reacts with polyoma virus large T antigen, which has an identical amino-terminal heptapeptide sequence except that Lys is replaced by Arg and Asn by Ser. " 02/05/1989 - "A radioiodinated synthetic analog of this peptide (Tyr-Leu-Val-Asp-Ser-Leu-Leu-Gln-Val-Leu-Asn-Val-Lys-Glu-Gly-Thr-Pro-Ser ) bound specifically to a small cell cancer line with high affinity, suggesting possible biological activity of the isolated peptide."
4.	Intracranial Vasospasm 01/01/1993 - "The present study was designed to determine whether an endothelinA (ETA)-receptor antagonist BQ-123 (cyclo[Dtrp, Dasp, pro-D-Val-Leu]) or an ET-converting enzyme inhibitor phosphoramidon may prevent development of cerebral vasospasm after subarachnoid hemorrhage (SAH). "
5.	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/01/1993 - "The present study was designed to determine whether an endothelinA (ETA)-receptor antagonist BQ-123 (cyclo[Dtrp, Dasp, pro-D-Val-Leu]) or an ET-converting enzyme inhibitor phosphoramidon may prevent development of cerebral vasospasm after subarachnoid hemorrhage (SAH). "

Related Drugs and Biologics

1.	Leucine (L-Leucine)
2.	Lysine (L-Lysine)
3.	Arginine (L-Arginine)
4.	carbobenzoxyglycylglycine
5.	glycylproline (Gly-Pro)
6.	leucylleucine (Leu-Leu)
7.	valylvaline (Val-Val)
8.	Amino Acids
9.	cyclo(Trp-Asp-Pro-Val-Leu)
10.	Enzyme Inhibitors (Inhibitors, Enzyme)

Related Therapies and Procedures

1.	Therapeutics
2.	Intravenous Infusions